The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBanco Santander Regulatory News (BNC)

Share Price Information for Banco Santander (BNC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 383.50
Bid: 388.00
Ask: 390.00
Change: -4.50 (-1.16%)
Spread: 2.00 (0.515%)
Open: 392.50
High: 393.00
Low: 383.50
Prev. Close: 388.00
BNC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

New issue: PCCS

18 Apr 2017 07:42

RNS Number : 5546C
Banco Santander S.A.
18 April 2017
 

 

 

 

 

MATERIAL FACT

Banco Santander, S.A. ("Banco Santander" or the "Bank") informs that its Executive Committee has resolved to carry out an issue of contingent perpetual preferred securities convertible into newly issued ordinary shares of the Bank, excluding pre-emptive subscription rights and for a nominal value of up to EUR € 2,000,000,000 (the "Issue"). The Issue will be carried out through an accelerated bookbuilding process and will be targeted only at qualified investors.

Banco Santander will disclose the final terms of the Issue once they have been decided.

 

Boadilla del Monte (Madrid), 18 April 2017

 

 

 

 

 

 

 

IMPORTANT INFORMATION

This material fact does not constitute an offer to sell, or the solicitation of an offer to buy any securities, nor shall there be any sale of such securities in any state of the United States or in another jurisdiction in which such offer, solicitation or sale would not be permitted before registration or qualification under the securities laws of such state or jurisdiction. The securities described above have not been registered under the U.S. Securities Act of 1933, as amended, or any applicable securities laws of any other jurisdiction. Unless so registered, such securities may not be offered or sold in the United States or any other jurisdiction except pursuant to an exemption from the registration requirements of the U.S. Securities Act of 1933, as amended, and any applicable securities laws of such other jurisdiction.

This material fact does not constitute an offer document or an offer of transferable securities to the public in the United Kingdom to which section 85 of the Financial Services and Markets Act 2000 ("FSMA") applies and should not be considered as a recommendation that any person should subscribe for or purchase any of the securities described herein. These securities will not be offered or sold to any person in the United Kingdom except in circumstances which have not resulted and will not result in an offer to the public in the United Kingdom in contravention of section 85(1) of FSMA.

This material fact does not constitute an offer to the public in Italy of financial products, as defined under article 1, paragraph 1, letter (t) of legislative decree no. 58 of 24 February 1998, as amended (the "Financial Services Act"). The preferred securities cannot be offered or sold in the Republic of Italy either on the primary or on the secondary market to any natural persons nor to entities other than qualified investors (investitori qualificati) as defined pursuant to Article 100 of the Financial Services Act and Article 34-ter, paragraph 1, letter b) of Regulation No. 11971 of May 14, 1999, as amended (the "Issuers Regulations") issued by the Commissione Nazionale per le Società e la Borsa, the Italian securities and financial markets regulator ("CONSOB") or unless in circumstances which are exempt from the rules on public offers pursuant to Article 100 of the Financial Services Act and the implementing CONSOB regulations, including the Issuers Regulations. This material fact is for informational purposes only and does not constitute and shall not, in any circumstances, constitute a public offering or an invitation to the public in connection with any offer within the meaning of the Directive 2003/71/EC of the European Parliament and of the Council of 4 November 2003 on the prospectus to be published when securities are offered to the public or admitted to trading.

No action has been made or will be taken that would permit a public offering of any securities described herein in any jurisdiction in which action for that purpose is required. No offers, sales, resales or delivery of any securities described herein or distribution of any offering material relating to any such securities may be made in or from any jurisdiction except in circumstances which will result in compliance with any applicable laws and regulations and which will not impose any obligation on the Company or the Joint Lead Managers or any of their respective affiliates. Additionally, the preferred securities will not be offered, distributed or sold in Spain nor to Spanish residents.

This material fact is an announcement and not a prospectus and investors should not subscribe for or purchase any securities referred herein except on the basis of the information in the offering circular.

Restrictions on Marketing and Sales to Retail Investors

The Preferred Securities are not intended to be sold and should not be sold to retail clients in the European Economic Area, as defined in the rules set out in the Product Intervention (Contingent Convertible Instruments and Mutual Society Shares) Instrument 2015 (as amended or replaced from time to time) (the "PI Rules") other than in circumstances that do not and will not give rise to a contravention of those rules by any person. By making or accepting an offer to purchase any Preferred Securities from the Issuer or the Joint Lead Managers, each prospective investor will be deemed to have represented, warranted, and undertaken to the Issuer and each of the Joint Lead Managers that (i) it is not a retail client; and (ii) it will not take any action which would result in a breach by the Issuer or any other person of the PI Rules (as defined herein). Potential investors should read the whole of the related offering circular, in particular the "Risk Factors" section and the "Restrictions on Marketing and Sales to Retail Investors" section.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCQVLBFDZFZBBB
Date   Source Headline
27th Apr 20203:07 pmRNS1Q 2020 results presentation announcement
3rd Apr 202011:43 amRNS2020 AGM - Resolutions
3rd Apr 202011:40 amRNS2020 AGM - Press Release
3rd Apr 20207:00 amRNSCommunication from the auditor of Banco Santander
3rd Apr 20207:00 amRNSResolutions of the Board of Directors: Dividends
30th Mar 20207:00 amRNSRevision of the rating by Fitch
24th Mar 20207:00 amRNSCoranvirus: 2020 dividend & compensation
23rd Mar 20204:25 pmRNS2nd additional notice in relation to the AGM call
17th Mar 20207:52 amRNSSantander Group Chairman presentation at MS EFC
10th Mar 20204:06 pmRNSDirector/PDMR Shareholding
10th Mar 20207:51 amRNSAdditional notice in relation to the call to AGM
2nd Mar 20204:20 pmRNSDirector/PDMR Shareholding
2nd Mar 20209:00 amRNSDirector/PDMR Shareholding
28th Feb 20203:38 pmRNSNotice of AGM
28th Feb 20201:33 pmRNSAnnual Financial Report
27th Feb 20204:20 pmRNSAnnouncement: AGM Notice of call
26th Feb 20204:29 pmRNSForm 8.3 - Sophos Group Plc
19th Feb 20204:15 pmRNSForm 8.3 - Sophos Group plc
17th Feb 20205:23 pmRNSDirector/PDMR Shareholding
17th Feb 20205:21 pmRNSDirector/PDMR Shareholding
17th Feb 20205:19 pmRNSDirector/PDMR Shareholding
17th Feb 20205:12 pmRNSDirector/PDMR Shareholding
17th Feb 20205:11 pmRNSDirector/PDMR Shareholding
17th Feb 20205:10 pmRNSDirector/PDMR Shareholding
13th Feb 202010:00 amRNSPost Stabilisation Notice
5th Feb 20203:07 pmRNSForm 8.3 - Sophos Group Plc
4th Feb 20207:09 amRNSDirector/PDMR Shareholding
3rd Feb 202011:29 amRNSDirector/PDMR Shareholding
3rd Feb 20207:53 amRNSDirector/PDMR Shareholding
3rd Feb 20207:05 amRNSDirector/PDMR Shareholding
29th Jan 20207:00 amRNSPR: 2019 Results & Remuneration for shareholders
29th Jan 20207:00 amRNS2019 financial report & analyst presentation
28th Jan 20202:59 pmRNSNotice of Results
15th Jan 202012:36 pmRNSNotice of Early Redemption
15th Jan 20207:41 amRNSEarly redemption of CoCos (Irrevocable decision)
9th Jan 20206:10 pmRNSPlacement of preferred securities
9th Jan 202010:06 amRNSPre Stabilisation Notice
9th Jan 20208:12 amRNSIntention of Early Redemption
8th Jan 20205:52 pmRNSForm 8.3 - Sophos Group plc
30th Dec 20193:18 pmRNSDirector/PDMR Shareholding
27th Dec 20198:02 amRNSNewport - Amendment
19th Dec 20199:11 amRNSDirector/PDMR Shareholding
16th Dec 201910:08 amRNSDirector/PDMR Shareholding
16th Dec 20197:35 amRNSDirector/PDMR Shareholding
11th Dec 20198:17 amRNS2020 prudential minimum capital requirements
2nd Dec 20199:05 amRNSDirector/PDMR Shareholding
28th Nov 20196:17 pmRNSMREL Resolution Group Banco Santander
20th Nov 20199:22 amRNSDirector/PDMR Shareholding
18th Nov 20199:43 amRNSDirector/PDMR Shareholding
15th Nov 20199:04 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.